CN103028080A

CN103028080A - Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis

Info

Publication number: CN103028080A
Application number: CN201210022711XA
Authority: CN
Inventors: 王遐
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-01-04
Filing date: 2012-01-04
Publication date: 2013-04-10

Abstract

The invention discloses a traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis. Traditional Chinese medicine doctors believe that the qi-stagnancy and blood stasis prostatitis belongs to the category of stranguria with turbid discharge and is mainly caused by retention of damp-heat and stagnation of turbid stasis. The traditional Chinese medicine decoction uses the traditional Chinese medicines with the efficacy of promoting blood circulation, removing blood stasis and promoting qi circulation to remove meridian obstruction including rhizoma ligustici wallichii, rhizoma corydalis, radix curcumae, leonurus heterophllus, turbid stasis, radix achyranthis bidentatae, caulis spatholobi, amomum cardamomum, cortex magnoliae officinalis, lignum santali albi and rhizoma cyperi, which are prepared into the decoction by the Preparation Room of Yishui Central Hospital of Linyi City, Shandong Province. The total effective rate of the medicine reaches 89.3 percent based on the clinical practice, which is obviously better than the control group; and the traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis is worthy of clinical popularization and application.

Description

A kind of prostatitic Chinese medicine QIANLIEKANG of qi stagnation and blood stasis type decoction for the treatment of

Technical field

The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine decoction for the treatment of chronic prostatitis.

Background technology

Chronic prostatitis is commonly encountered diseases, the frequently-occurring disease of Urology Surgery, also is refractory disease, comprises chronic bacterial prostatitis, chronic nonbacterial prostatitis and prostatodynia.Clinical account for about 1/3 of Urology Surgery male case take prime of life male morbidity as more, and the trend that rises is year by year arranged, its primary disease course of disease is touching, and relapse rate is high.Doctor trained in Western medicine is mainly take antibiotic therapy as main, and a large amount of clinical practices show that the chronic bacterial prostatitis proportion is less than 10%, simultaneously because prostatic specific position and anatomy relationship, most medicines are difficult to play a role, facts have proved that in a large number the traditional Chinese medical science has its unique curative effect and advantage in the treatment chronic prostatitis.

Summary of the invention

The purpose of this invention is to provide a kind of prostatitic Chinese medicine QIANLIEKANG of qi stagnation and blood stasis type decoction for the treatment of.The traditional Chinese medical science thinks that primary disease belongs to the stranguria with turbid discharge category, and the turbid retardance of damp-heat accumulation and the stasis of blood is the Etiological place of primary disease, clinically take blood circulation promoting and blood stasis dispelling, promoting of the circulation of QI and removing the obstruction in the collaterals as the rule for the treatment of.

The objective of the invention is to be achieved through the following technical solutions, the prostatitic Chinese medicine QIANLIEKANG of this treatment qi stagnation and blood stasis type decoction is made by the Chinese medicine of following weight portion: Rhizoma Chuanxiong 7-9 part, Rhizoma Corydalis 10-12 part, Radix Curcumae 6-8 part, Herba Leonuri 12-15 part, Radix Achyranthis Bidentatae 7-9 part, Caulis Spatholobi 5-7 part, Fructus Amomi Rotundus 10-12 part, Cortex Magnoliae Officinalis 12-15 part, Lignum Santali Albi 7-9 part, Rhizoma Cyperi 5-7 part.

Preferably, the prostatitic Chinese medicine QIANLIEKANG of this treatment qi stagnation and blood stasis type decoction is made by the Chinese medicine of following weight portion: 8 parts of Rhizoma Chuanxiongs, 11 parts of Rhizoma Corydalis, 7 parts of Radix Curcumaes, 13 parts of Herba Leonuris, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Caulis Spatholobis, 11 parts of Fructus Amomi Rotunduss, 13 parts of Cortex Magnoliae Officinalis, 8 parts in Lignum Santali Albi, 6 parts of Rhizoma Cyperis.

In the side: Rhizoma Chuanxiong, Rhizoma Corydalis, Radix Curcumae blood-activating and qi-promoting, wind-expelling pain-stopping, resolving depression mood; Herba Leonuri, Caulis Spatholobi, Radix Achyranthis Bidentatae promoting blood circulation to restore menstrual flow, relaxing muscles and tendons and activating QI and blood in the collateral; Fructus Amomi Rotundus, Cortex Magnoliae Officinalis circulation of qi promoting are wet dry, the warming middle-JIAO removing food stagnancy; Lignum Santali Albi, Rhizoma Cyperi depressed liver-energy dispersing and QI regulating are during cold expelling is transferred.

Clinical data

1, physical data is originally organized 156 routine cases and is my institute outpatient service and the inpatient in year October in May, 2007 to 2008, all meets the diagnostic criteria of chronic prostatitis in " practical combination of Chinese and Western medicine diagnoses and treatment ".The patient is divided into two groups at random, treatment group 84 examples, matched group 72 examples.18 years old～30 years old treatment group age person's 42 examples, 31 years old～40 years old person's 30 examples, 41 years old～50 years old person's 12 examples; Course of disease half a year～1 year person 18 examples, 1 year～2 years person's 30 examples, 2 years～3 years person's 24 examples, person's 12 examples more than＞3 years.18 years old～30 years old matched group age person's 30 examples, 31 years old～40 years old person's 24 examples, 41 years old～50 years old person's 18 examples; Course of disease half a year～1 year person 10 examples, 1 year～2 years person's 26 examples, 2 years～3 years person's 24 examples, person's 12 examples more than＞3 years.Two groups of ages, courses of disease compare, and no significant difference (P＞0.05) has comparability.

2, the Therapeutic Method treatment group is taken QIANLIEKANG decoction of the present invention.Get Rhizoma Chuanxiong 8g, Rhizoma Corydalis 11g, Radix Curcumae 7g, Herba Leonuri 13g, Radix Achyranthis Bidentatae 8g, Caulis Spatholobi 6g, Fructus Amomi Rotundus 11g, Cortex Magnoliae Officinalis 13g, Lignum Santali Albi 8g, Rhizoma Cyperi 6g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.Matched group is taken the QIANLIEKANG PIAN that Zhejiang Kang Enbei pharmaceutical Co. Ltd produces, every 0.5g, each 3～4,3 times on the one.Two groups all take 15 days as a course for the treatment of, finish 2 courses for the treatment of news commentary constant current modulation effect.Period in a medicine other antagonism cooperative drug of stopping using.

3, criterion of therapeutical effect recovery from illness: the clinical symptoms integration reduces 〉=95%, and the prostate tenderness disappears, and quality is normal or approaching normal, and EPS checks continuous normal more than 2 times; Effectively: the clinical symptoms integration reduces 30%～95%, and prostate tenderness and quality all have clear improvement.EPS checks the continuous front minimizing 30%～60% for the treatment of of WBC counting more than 2 times; Invalid: all without improving, EPS checks the continuous front minimizing＜30% or unchanged for the treatment of of WBC counting more than 2 times for clinical symptoms integration minimizing＜30% or unchanged, prostate tenderness and quality.

4, therapeutic outcome

(1) curative effect relatively.Treatment group 84 examples, 32 examples of wherein fully recovering (38.1%), effective 43 examples (51.2%), no effect 9 (10.7%), total effective rate 89.3%; Matched group 72 examples, 19 examples of wherein fully recovering (26.4%), effective 27 examples (37.5%), invalid 26 examples (36.1%), total effective rate 63.9%; The curative effect for the treatment of group is better than matched group (P＜0.05).

(2) the NIH-CPSI scoring is observed.Two groups of rear patients' for the treatment of pain, the symptom of urinating and quality of life all is improved (all P＜0.05) before the treatment, but treatment group improvement in these areas also all is better than matched group (P＜0.05).

The specific embodiment

Embodiment one: take by weighing Rhizoma Chuanxiong 8g, Rhizoma Corydalis 11g, Radix Curcumae 7g, Herba Leonuri 13g, Radix Achyranthis Bidentatae 8g, Caulis Spatholobi 6g, Fructus Amomi Rotundus 11g, Cortex Magnoliae Officinalis 13g, Lignum Santali Albi 8g, Rhizoma Cyperi 6g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.

Embodiment two: take by weighing Rhizoma Chuanxiong 9g, Rhizoma Corydalis 10g, Radix Curcumae 8g, Herba Leonuri 12g, Radix Achyranthis Bidentatae 9g, Caulis Spatholobi 5g, Fructus Amomi Rotundus 10g, Cortex Magnoliae Officinalis 15g, Lignum Santali Albi 7g, Rhizoma Cyperi 5g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.

Embodiment three: take by weighing Rhizoma Chuanxiong 7g, Rhizoma Corydalis 12g, Radix Curcumae 6g, Herba Leonuri 15g, Radix Achyranthis Bidentatae 7g, Caulis Spatholobi 7g, Fructus Amomi Rotundus 12g, Cortex Magnoliae Officinalis 12g, Lignum Santali Albi 9g, Rhizoma Cyperi 7g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.

Claims

1. treatment qi stagnation and blood stasis type prostatitic Chinese medicine QIANLIEKANG decoction is characterized in that this Chinese medicine QIANLIEKANG decoction made by the Chinese medicine of following weight portion: Rhizoma Chuanxiong 7-9 part, Rhizoma Corydalis 10-12 part, Radix Curcumae 6-8 part, Herba Leonuri 12-15 part, Radix Achyranthis Bidentatae 7-9 part, Caulis Spatholobi 5-7 part, Fructus Amomi Rotundus 10-12 part, Cortex Magnoliae Officinalis 12-15 part, Lignum Santali Albi 7-9 part, Rhizoma Cyperi 5-7 part.

2. a kind of prostatitic Chinese medicine QIANLIEKANG of qi stagnation and blood stasis type decoction for the treatment of according to claim 1 is characterized in that this Chinese medicine QIANLIEKANG decoction made by the Chinese medicine of following weight portion: 8 parts of Rhizoma Chuanxiongs, 11 parts of Rhizoma Corydalis, 7 parts of Radix Curcumaes, 13 parts of Herba Leonuris, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Caulis Spatholobis, 11 parts of Fructus Amomi Rotunduss, 13 parts of Cortex Magnoliae Officinalis, 8 parts in Lignum Santali Albi, 6 parts of Rhizoma Cyperis.